Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT02139657 | An Open-label, Single-Arm Study to Evaluate the Safety and Rabies Virus Antibody Titers of Intramuscularly Administered Rabies Immune Globulin (Human) | PHASE1 | COMPLETED | 12 | — | — | Mar 1, 2014 | May 1, 2014 | Jul 24, 2014 | 1 | United States |
| Arm | Type | Description |
|---|---|---|
| RIG-C | EXPERIMENTAL | Single 20 IU/kg dose of RIG-C by intramuscular injection |
| Name | Type | Description |
|---|---|---|
| RIG-C | BIOLOGICAL | - |
Inclusion Criteria: * In good health in the judgment of the Investigator as determined by medical history, physical examination, and screening laboratory assessments. * Female of childbearing potential must have a negative result on the screening serum pregnancy test and must agree to practice cont...